Opportunity Information: Apply for CDC RFA CK12 120905CONTPPHF16
Apply for CDC RFA CK12 120905CONTPPHF16
- The HHS-CDC-NCEZID in the health sector is offering a public funding opportunity titled "PPHF 2016: Epidemiology and Laboratory Capacity Program – Emerging Infections Programs – Financed in part by 2016 Prevention and Public Health Funds" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.521.
- This funding opportunity was created on Mar 25, 2016 and posted on Mar 25, 2016.
- Applicants must submit their applications by May 02, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "PPHF 2016: Epidemiology and Laboratory Capacity Program - Emerging Infections Programs - Financed in part by 2016 Prevention and Public Health Funds," is a CDC continuation cooperative agreement intended to support ongoing work under the Epidemiology and Laboratory Capacity (ELC) Program, specifically within the Emerging Infections Programs (EIP) component. It is administered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), through the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). The listing is associated with CFDA number 93.521 and is supported in part by Prevention and Public Health Funds (PPHF) allocated for fiscal year 2016.
The opportunity is categorized as continuation funding, which generally means it is designed for entities that already have an existing award or established role under the program and are eligible to continue their approved activities rather than compete as entirely new applicants. The funding instrument is a cooperative agreement, signaling that CDC expects to have substantial programmatic involvement. In practice, that usually includes close collaboration with CDC on technical approaches, performance monitoring, guidance on surveillance standards, laboratory methods, data management, and reporting expectations. Cooperative agreements often emphasize alignment with national surveillance priorities and standardized methods so results can be compared across sites and used for national situational awareness.
Programmatically, the Emerging Infections Programs are typically focused on strengthening public health capacity to detect, track, and respond to emerging or re-emerging infectious disease threats. Within an ELC context, that usually includes building and sustaining epidemiologic surveillance systems, enhancing laboratory capacity, improving timeliness and quality of case detection and reporting, and supporting applied public health research and evaluation that can inform prevention and control strategies. The overall intent is to maintain robust state or regional infrastructure that can generate high-quality data on infectious diseases, identify outbreaks earlier, and support evidence-based interventions.
The eligibility field indicates "Others (see text field entitled Additional Information on Eligibility for clarification)," which commonly points to restricted eligibility defined in the full announcement or companion guidance. Given it is explicitly a continuation announcement, it typically targets existing recipients or designated participants in the EIP network rather than open, broad eligibility for any organization. The announcement was created and posted on March 25, 2016, with an original and current closing date of May 2, 2016, reflecting a relatively short application or continuation submission window consistent with ongoing program funding cycles.
Several administrative fields in the source data are either blank or set to zero, including an award ceiling of 0 and no value shown for expected awards. In federal postings, that often means the specific dollar amounts, number of awards, or ceilings were either not provided in the summary record, are determined through continuation budgets and negotiated workplans, or are described only in the full funding announcement rather than in the metadata extract. The key takeaway from the listing is that it is a CDC-led continuation cooperative agreement under CFDA 93.521, supporting ELC/EIP activities financed in part by the FY 2016 Prevention and Public Health Funds, with the goal of sustaining and strengthening epidemiology and laboratory capacity for emerging infectious disease surveillance and response.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled "PPHF 2016: Epidemiology and Laboratory Capacity Program - Emerging Infections Programs - Financed in part by 2016 Prevention and Public Health Funds."
Which federal agency is offering and administering this opportunity?
This opportunity is administered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), through the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID).
What type of award is this (grant vs. cooperative agreement)?
The funding instrument is a cooperative agreement, which indicates CDC expects substantial programmatic involvement in the funded work.
What does "cooperative agreement" imply for how the work will be carried out?
Based on the description, a cooperative agreement typically involves close collaboration with CDC. This can include CDC involvement in technical approaches, performance monitoring, guidance on surveillance standards, laboratory methods, data management, and reporting expectations, with an emphasis on alignment to national surveillance priorities and standardized methods.
Is this a new competitive opportunity or continuation funding?
This is categorized as continuation funding. It is intended to support ongoing work under an existing program structure rather than function as a fully open competition for entirely new applicants.
Who is eligible to apply?
The eligibility field is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)." Given that this is explicitly a continuation announcement, it typically targets existing recipients or designated participants in the Emerging Infections Programs (EIP) network rather than broad, open eligibility for any organization.
What program does this opportunity support?
This opportunity supports ongoing work under the CDC Epidemiology and Laboratory Capacity (ELC) Program, specifically within the Emerging Infections Programs (EIP) component.
What is the purpose of the Emerging Infections Programs (EIP) in this context?
As described, EIP activities are typically focused on strengthening public health capacity to detect, track, and respond to emerging or re-emerging infectious disease threats.
What kinds of activities does this opportunity generally support?
Within an ELC context, the description notes activities that usually include building and sustaining epidemiologic surveillance systems, enhancing laboratory capacity, improving the timeliness and quality of case detection and reporting, and supporting applied public health research and evaluation to inform prevention and control strategies.
What is the overall intent or goal of the funding?
The overall intent is to maintain robust state or regional infrastructure that can generate high-quality infectious disease data, identify outbreaks earlier, and support evidence-based interventions.
What is the CFDA number associated with this opportunity?
The listing is associated with CFDA number 93.521.
How is this opportunity funded?
This opportunity is financed in part by Prevention and Public Health Funds (PPHF) allocated for fiscal year 2016.
When was the opportunity posted?
The announcement was created and posted on March 25, 2016.
What is the application or submission deadline?
The original and current closing date listed is May 2, 2016.
Why might the application window be relatively short?
The description notes that continuation announcements often have a short submission window, consistent with ongoing program funding cycles and the continuation nature of the work.
Is there an award ceiling listed for this opportunity?
Several administrative fields in the source data are blank or set to zero, including an award ceiling of 0. This often indicates the ceiling was not provided in the summary record or is determined through continuation budgets and negotiated workplans, or it may be described only in the full funding announcement rather than in the metadata extract.
Does the posting specify the expected number of awards or total funding?
No. The summary record shows no value for expected awards, and certain financial fields appear blank or set to zero. The description suggests those details may be determined through continuation processes or provided in the full announcement rather than in the summary metadata.
What is the main takeaway from the listing if funding amounts are not shown?
The main takeaway is that this is a CDC-led continuation cooperative agreement under CFDA 93.521, supporting ELC/EIP activities and financed in part by FY 2016 PPHF, aimed at sustaining and strengthening epidemiology and laboratory capacity for emerging infectious disease surveillance and response.
Browse more opportunities from the same category: Health
Next opportunity: FY16 Region 05 Wetland Program Development Grants
Previous opportunity: PPHF 2016: Immunization Grants - Increasing IIS Sentinel Site Capacity for Enhanced Program Support – Financed in part by 2016 Prevention and Public Health Funds
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA CK12 120905CONTPPHF16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA CK12 120905CONTPPHF16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Collecting Violent Death Information Using the National Violent Death Reporting System (NVDRS) Apply for CDC RFA CE16 1607 Funding Number: CDC RFA CE16 1607 Agency: HHS-CDC-NCIPC Category: Health Funding Amount: $878,000 |
| Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R01) Apply for PAR 16 154 Funding Number: PAR 16 154 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R21) Apply for PAR 16 153 Funding Number: PAR 16 153 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| NeuroNEXT Clinical Trials (U01) Apply for PAR 16 155 Funding Number: PAR 16 155 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Newborn Screening Implementation Program Regarding Conditions Added to the Recommended Uniform Screening Panel (RUSP) Apply for HRSA 16 062 Funding Number: HRSA 16 062 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Use of Imaging and Digital Image Analysis Software/s to Evaluate Transdermal Irritation and Non - inferiority of Generic Transdermal Products (U01) Apply for RFA FD 16 010 Funding Number: RFA FD 16 010 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Generic Drug Substitution in Special Populations (U01) Apply for RFA FD 16 011 Funding Number: RFA FD 16 011 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Adult Maturational Changes and Dysfunctions in Emotion Regulation (R01) Apply for RFA MH 17 405 Funding Number: RFA MH 17 405 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Preventing Teen Dating and Youth Violence by Addressing Shared Risk and Protective Factors Apply for CDC RFA CE16 1605 Funding Number: CDC RFA CE16 1605 Agency: HHS-CDC-NCIPC Category: Health Funding Amount: $412,500 |
| TRANSFORM/Primary Health Care Unit (PHCU) Apply for APS 663 16 000005 Funding Number: APS 663 16 000005 Agency: USAID-ETH Category: Health Funding Amount: $120,000,000 |
| NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) Apply for PAR 16 156 Funding Number: PAR 16 156 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) grants Apply for TI 16 014 Funding Number: TI 16 014 Agency: HHS-SAMHS Category: Health Funding Amount: $1,000,000 |
| Prevention Innovation Program III (PIP) (R01) Apply for RFA AI 16 025 Funding Number: RFA AI 16 025 Agency: HHS-NIH11 Category: Health Funding Amount: $400,000 |
| National Implementation and Dissemination for Chronic Disease Prevention Apply for CDC RFA DP14 141803CONT16 Funding Number: CDC RFA DP14 141803CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strategic Prevention Framework for Prescription Drugs (SPF Rx) Apply for SP 16 006 Funding Number: SP 16 006 Agency: HHS-SAMHS Category: Health Funding Amount: $371,616 |
| Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths (PDO) Apply for SP 16 005 Funding Number: SP 16 005 Agency: HHS-SAMHS Category: Health Funding Amount: $11,000,000 |
| Partnerships for Countermeasures against Select Pathogens (R01) Apply for RFA AI 16 034 Funding Number: RFA AI 16 034 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| HPV Roundtable: Creating a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination- Financed in Part by 2016 Prevention and Public Health Funds Apply for CDC RFA IP16 1602PPHF16 Funding Number: CDC RFA IP16 1602PPHF16 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $500,000 |
| New Technologies for the Glycosciences (R41/R42) Apply for PA 16 158 Funding Number: PA 16 158 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Cooperative Agreements for Tribal Behavioral Health Apply for SM 16 010 Funding Number: SM 16 010 Agency: HHS-SAMHS Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA CK12 120905CONTPPHF16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.